mRNA cancer vaccine granted world-first approval
By Catherine Eckford (European Pharmaceutical Review)
Potential best-in-class antibody shows “remarkable efficacy” in atopic dermatitis
By Catherine Eckford (European Pharmaceutical Review)
Pioneering the next wave of LBP-based therapeutics
By Christopher Weidenmaier (mbiomics), Johannes B. Woehrstein (mbiomics)
Combination treatment could provide new standard-of-care for aggressive lymphoma
By Catherine Eckford (European Pharmaceutical Review)
Pioneering the next wave of LBP-based therapeutics
By Christopher Weidenmaier (mbiomics), Johannes B. Woehrstein (mbiomics)
What is the future of biologic medicines?
By Catherine Eckford (European Pharmaceutical Review), Sigma Mostafa (KBI Biopharma)